Evotec initiates phase II proof-of-concept EVT-302 trial in smoking cessation Sep. 16, 2008 No Comments
Cortex reports positive results from RD-02 phase IIa clinical trial of Ampakine in RD Aug. 11, 2008 No Comments
University of Texas Southwestern Medical Center initiates clinical trial of DOR's RiVax Aug. 8, 2008 No Comments
Cleveland receives notice of allowance from FDA to initiate phase I trial of Protectan CBLB-502 Aug. 8, 2008 No Comments
Titan presents positive phase III results for Probuphine in opioid addiction July 30, 2008 No Comments
Novel kappa opioid receptor antagonist zyklophin has therapeutic potential in drug abuse July 18, 2008 No Comments
Sublingual buprenorphine safe and effective in controlling neonatal abstinence syndrome July 17, 2008 No Comments
RSS